Balanced news tone
News Sentiment
8158 sentiment intelligence
China Regenerative Medicine International Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
71/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, -11.1% over four weeks, trend inactive, and below fair value.
Enterprise value to EBIT forward of China Regenerative Medicine International Limited – HKEX:8158
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to EBIT forward of China Regenerative Medicine International Limited – HKEX:8158
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:21
- Source
- TradingView
Price to sales forward of China Regenerative Medicine International Limited – HKEX:8158
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:31
- Source
- TradingView
China Regenerative Medicine International Limited (Stock Code: 8158) and twelve of its current and former directors censured or criticised for breaching the GEM Listing Rules and the Director’s Undertaking
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2019 07:00
- Source
- hkex.com.hk
EQS-News: CRMI: China Regenerative Medicine International Limited Partner with University of Oxford and CCB International (Holdings) Limited Establishing a Strategic Platform for Industrialisation of Biomedical Research Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Oct 2015 07:00
- Source
- TMX Newsfile